At the end of the latest market close, Forward Pharma A/S (FWP) was valued at $7.90. In that particular session, Stock kicked-off at the price of $7.41 while reaching the peak value of $9.83 and lowest value recorded on the day was $7.4044. The stock current value is $7.58.
Recently in News on April 14, 2021, Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020. Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated financial results for the year ended December 31, 2020. Our net loss for the year ended December 31, 2020 was $6.4 million, or $0.07 per share, versus a net loss of $4.2 million, or $0.04 per share for the year ended December 31, 2019. Our research and development and general and administrative costs decreased from $5.3 million for the year ended December 31, 2019 to $3.4 million for the year ended December 31, 2020. Our net loss for the year ended December 31, 2020 was unfavorably impacted by a significant non-cash foreign exchange loss of $3.0 million that is primarily related to our U.S. Dollar cash holdings and the weakening of the U.S. Dollar compared to the Danish Kroner.“We continue to be well positioned financially as we enter into 2021 with cash holdings of $79.1 million and working capital of $78.6 million. We believe we have the financial strength to fund operations beyond 2021 and focus on the oral proceedings before the Technical Board of Appeals that are scheduled for September 6, 2021 after two postponements caused by the ongoing coronavirus pandemic,” said Dr. Claus Bo Svendsen, Chief Executive Officer of Forward. You can read further details here
Forward Pharma A/S had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $10.15 on 02/11/21, with the lowest value was $6.43 for the same time period, recorded on 01/13/21.
Forward Pharma A/S (FWP) full year performance was 21.54%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Forward Pharma A/S shares are logging -25.32% during the 52-week period from high price, and 31.82% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $5.75 and $10.15.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 895494 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Forward Pharma A/S (FWP) recorded performance in the market was 12.37%, having the revenues showcasing 12.06% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 53.56M, as it employees total of 4 workers.
Market experts do have their say about Forward Pharma A/S (FWP)
During the last month, 0 analysts gave the Forward Pharma A/S a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.33, with a change in the price was noted +1.01. In a similar fashion, Forward Pharma A/S posted a movement of +15.21% for the period of last 100 days, recording 103,970 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for FWP is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Forward Pharma A/S (FWP)
Raw Stochastic average of Forward Pharma A/S in the period of last 50 days is set at 29.88%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 26.01%. In the last 20 days, the company’s Stochastic %K was 33.87% and its Stochastic %D was recorded 37.72%.
Bearing in mind the latest performance of Forward Pharma A/S, several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 12.37%. Additionally, trading for the stock in the period of the last six months notably improved by 10.03%, alongside a boost of 21.54% for the period of the last 12 months. The shares increased approximately by 7.63% in the 7-day charts and went up by 4.50% in the period of the last 30 days. Common stock shares were driven by 12.06% during last recorded quarter.